Requiring the Maryland Medical Assistance Program to establish reimbursement levels, rather than maximum reimbursement levels, for drug products for which there is a certain generic equivalent; requiring that certain minimum reimbursement levels be at least equal to the National Average Drug Acquisition Cost of the generic product plus the fee-for-service professional dispensing fee determined by the Maryland Department of Health in accordance with the most recent in-State cost-of-dispensing survey; etc.
Bill File Type: Regular
Effective Date(s): Upon Enactment
( 15-1632 )
Last Updated: 2/28/2020 8:50 AM